UPDATE August 2024 and Opinion Question - Advanced Prostate...

Advanced Prostate Cancer

22,373 members28,135 posts

UPDATE August 2024 and Opinion Question

APCFighter profile image
24 Replies

Update:

Traveled to Jacksonville, FL to get a second opinion from the Mayo Clinic.

Got all of my IU Health Doctors agree to consult with my Mayo Doctors when they need some guidance and when I ask. Beginning valuable connections.

Restarted started a Lupron shot every 3 months.

Started Enzalutamide (160Mg daily) and

Another CT scan to help RO design a stereotactic body radiotherapy (SBRT) program

Start SBRT in August 2024

Opinions request: Should I be pushing for Triplet Therapy?

Written by
APCFighter profile image
APCFighter
To view profiles and participate in discussions please or .
Read more about...
24 Replies
dhccpa profile image
dhccpa

I saw Dr. Winston Tan at Mayo JAX about five years ago, but wound up sticking with local MO. Recently, I called them about Provenge immunotherapy but they quit using it at some point.

I like the facility there, though. I accompany a friend who had major colon cancer treatment there beginning in 2017. Always a pleasant environment, easy to park (but getting harder!).

APCFighter profile image
APCFighter in reply todhccpa

Yes - we really liked it there.

E2-Guy profile image
E2-Guy

I refused to subject myself to the nasty Lupron injections 20 years ago for my prostate cancer. All I ever did was to apply Oestrogel which I buy OTC here in Thailand. Haven't done anything for over 10 years. and my PSA is undetectable. I'm now 81. I believe my cancer has been asleep for a number of years?

My email address is: ronpitelka@yahoo.com

mperloe profile image
mperloe in reply toE2-Guy

Yet there is research showing that estrogen may promote growth of the cancer. You are lucky.

dhccpa profile image
dhccpa in reply tomperloe

Some on here have said the PATCH trial supported estrogen use as an alternative to Lupron/Firmagan, etc.

What's your take on the PATCH trial?

Break60 profile image
Break60 in reply todhccpa

I read it and switched off Lupron many years ago and changed to (3 ) .1 mg. Estradiol patches changed weekly . Lot fewer side effects!

dhccpa profile image
dhccpa in reply toE2-Guy

Sounds like you're doing great. I was wondering how you were doing. Carry on!

mperloe profile image
mperloe

Triplet would be useful for high volume metastatic disease. Have you done genetic and genomic somatic testing?

APCFighter profile image
APCFighter in reply tomperloe

Thank you for your reply. I had a full genetic analysis and they didn't find anything that associates with Prostate Cancer and have any treatment for. I certainly would not call my "high volume metastatic" as I only have 3 small spots.

E2-Guy profile image
E2-Guy in reply tomperloe

No! I'm 81, and my PSA has been undetectable for a number of years , so I'm not even concerned about PCa anymore. I stopped using E2 for about three years. If my PSA ever starts rising, I may consider your suggestion.

mperloe profile image
mperloe in reply toE2-Guy

It's always great to meet people in the been there done that club.

Break60 profile image
Break60 in reply toE2-Guy

Hi I remember us chatting awhile back. Glad to hear you’re still undetectable! My Pca was pretty much under control after switching to Estradiol patches and adding Xgeva when psa started to climb. Everything was cool for three years but Now neither are working so I’m about to take a step in another direction. A psma CTPET scan found more bone Mets and my inclination is to have them zapped with SBRT as I did with prior oligometastatic bone Mets. I’m speaking with my MO today to work out a plan. BTW I turn 81 in January and have had Pca since 2013 at age 69. I can’t do chemo due to peripheral neuropathy. Plus I hate the thought of poisoning myself.

E2-Guy profile image
E2-Guy in reply toBreak60

Do you still have your prostate?

Break60 profile image
Break60 in reply toE2-Guy

No that was removed in 2013 at John’s Hopkins.

mperloe profile image
mperloe

Then doublet therapy plus RT seem to be what most MDs would recommend. Perhaps a clinical trial would be more aggressive.

APCFighter profile image
APCFighter in reply tomperloe

Thanks. Good to know.

DLimey profile image
DLimey

I’ve read a few medical journal articles that suggest doublet, not triplet is the best approach for ductal subtype. I will try to find those references for you. And we see the MO in 10 days and will report back what we learn.

DLimey profile image
DLimey

Just back from Mayo Rochester. Amazing visit! We had a list of questions and he answered them all. We have a plan, he’s starting a clinical trial aimed at reducing the ADT toxicity for lower volume, distant, recurrent mets. MO’s exact words “If someone suggests chemo, Slam the door in their face! It is not the right treatment for you!”

APCFighter profile image
APCFighter

Great info - thank you very much! Can you share any details of how his trial will attempt to reduce the ADT toxicity? Good luck in your journey!

DLimey profile image
DLimey

cancer.gov/clinicaltrials/N...

DLimey profile image
DLimey

He’ll have SBRT for the low level distant mets then randomized to either no adt or a 6 month course of Nubeqa + lupron. Being able to continue with his career is important to him. This trial provides the best opportunity for that. Frequent travel to Rochester for 4 months, a trade off to the long term soc adt.

APCFighter profile image
APCFighter

If you don't mind telling, how did you learn of this trial?

DLimey profile image
DLimey in reply toAPCFighter

We were getting some pushback that it was too early whenever we mentioned an MO consult with the RO PA, so I asked hubs to look outside his cancer center. It was a guy on the Metastatic PC group in FB that suggested the MO group at Mayo Rochester - we’d considered Dr. Kwon, but hadn’t looked at the MO group there. It was impressive compared to our local options. In the intake they asked if he would be interested in clinical trials and he’d answered Yes. The MO was who accepted his case is who thought he was a good candidate for this study. He’d invited the study coordinator to listen in on our appointment. There was another test was recently filled that would have been another good option. Our RO also likes this one for us. He said the local studies at his center are usually only for newly diagnosed with mets, not recurrent disease.

DLimey profile image
DLimey in reply toDLimey

With the new PSMA able to find early disease progression, they said there are quite a few trials in the low level disease space.

Not what you're looking for?

You may also like...

Doc Rok Update

Hello folks. I am scheduled for a surgery at Mayo clinic to remove my seminal vesicles (SV's) and...
docrok profile image

Update and 2nd opinion

Hello again, I have asked a couple questions at the beginning of this journey and it has been very...
JD-guy profile image

Update

For those who have followed me, my pc has taken a backseat to my Glio tumor. I had SBRT and...
PabloK profile image

State of the Art Radiation Therapy Equipment

I just attended at talk by a Radiation Oncologist talking about: (a) Intensity-modulated...
cesanon profile image

SBRT or IMRT

trying to make big decision Any insight, thoughts or experiences appreciated. My husband has...
Klunacat profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.